PART 1: Dr. Richard Urso: Alarming Post-Booster Trends and the Censorship of Treatments for COVID-19
“All of a sudden when the word COVID-19, coronavirus, came up, there was no treatment for inflammation, no treatment for respiratory compromise, no treatment for blood clotting. How is that possible? It’s completely absurd.”
During the COVID-19 pandemic, standard protocols for finding treatments were thrown out of the window, says Dr. Richard Urso, a co-founder of the International Alliance of Physicians and Medical Scientists, which organizes Global Covid Summit events.
“There is a way to mitigate damage in every disease, whether it’s COVID, whether it’s cancer … We look for the things that have the most evidence, the most biologic plausibility, and then we go from there,” says Urso.
Urso is a drug design and treatment specialist, an ophthalmologist, and former chief of orbital oncology at MD Anderson Cancer Center.
We discuss how science has been corrupted and we also take a look at many alarming trends he’s seen primarily in individuals who have received their third or fourth vaccine booster shot.
Jan Jekielek: Dr. Richard Urso, such a pleasure to have you on American Thought Leaders.
Dr. Richard Urso: It’s great to be here. Looking forward to our discussion.
Mr. Jekielek: I’m going to read you a headline, “17,000 physicians and medical scientists declare the COVID national emergency over.” You’re one of them.
Dr. Urso: I’m one of the founders. We started back in August of 2021, looking at the pandemic and seeing it getting out of control. We decided to band together so we could send a stronger message.
Mr. Jekielek: Just very quickly, who is it that’s banding together here?
Dr. Urso: It was myself, Robert Malone, John Littell, Heather Gessling, Brian Tyson, Ryan Cole, and Mark McDonald. We had several others that were very interested but couldn’t make the trip to Puerto Rico. We went down to Puerto Rico to band together and to figure out a strategy on how we could move forward in the pandemic when we were literally not doing very well with treatment. We were having a lot of difficulty with supply chain issues, with getting Ivermectin, Hydroxychloroquine, and all the other drugs. We were having troubles with pharmacists. We were having media issues and being branded as not doing the right thing.
Clearly for us, there is always treatment for every disorder, and it was so simple. There’s inflammation, there’s respiratory demise, there’s blood clotting, and of course, we have drugs for those things. How could we not? Then we have biologically plausible mechanisms to fight the virus with things like Ivermectin and other drugs.
This is not a willy-nilly thing, this is something that’s done. There’s a lot of information in PubMed describing how these drugs might be useful. We wanted to make sure that we had an organization that could be difficult to take down. If we could band together, we felt like we could have a stronger voice. So we ended up coming together. Now, we have 18,000 physicians and scientists, which I love to say, is more than the NEH, the CDC, and the FDA. For the most part, our guys are likely smarter, since most of our guys are from MIT and Harvard and Stanford, a lot of great universities.
Mr. Jekielek: What is the organization’s name?
Dr. Urso: It’s called the International Alliance of Physicians and Scientists. We have a subgroup for our organizations’ meetings called the Global COVID Summit.
Mr. Jekielek: That’s where most people have heard of the group. Is the emergency over? How can we tell?
Dr. Urso: If we’re looking at it without a political eye, the emergency is over. COVID has slowed down. Omicron has gone throughout most of the population, particularly all the vaccinated people, it’s pretty well made its way through. In places like England, 90 per cent of the people dying of COVID right now, and dying of Omicron, were triple-vaccinated people. But it acted like a vaccine for the people who survived. So the risk of COVID through the general population in the United States is very low right now. In all likelihood, we’ve reached what we would consider to be herd immunity, which of course has a definition that has changed recently. That’s why I think we’re in a good place with COVID right now.
Mr. Jekielek: How has the definition changed? I remember looking at this earlier.
Dr. Urso: Herd immunity has taken on this new definition of somebody who wants people to die of COVID by letting people get infected with the disease. It’s taken on this definition through the media. Someone who talks about it doesn’t really care about humankind, and is somebody who thinks that vaccination is not a way forward.
There was really no reason for that. In a sense, herd immunity says that if enough people get sick with an illness from a virus that’s fairly stable, like chicken pox, for instance, that virus will now have a lot of difficulty spreading through the population. Because as it skips from me to you, if you’ve already had it you can’t spread it, because you can’t acquire it. You already have immunity.
This ties in with the fraud of the government of saying that natural immunity doesn’t matter. Today, I heard a famous person in Canada still saying, “Natural immunity only lasts six months,” which is absurd. For people who don’t know, the natural immunity from SARS-CoV-1 lasts 18 years. So natural immunity is long, broad, and durable. It likely lasts for life duration, and at least for decades. We have 151 studies showing that natural immunity is superior to vaccinated immunity.
Mr. Jekielek: Herd immunity is something that happens when a virus is going through the population. Yet, it became a strange pejorative term, as was described earlier.
Dr. Urso: Exactly. It’s become a pejorative term, rather than just a way to just discuss this science; populations exposed to certain infections will create the inability for that same infection to spread, because so many people have already developed an immunity to, say, measles, or any of these well-known viruses.
Mr. Jekielek: Are you saying that you’re not expecting another wave of this virus?
Dr. Urso: That’s a good question. There’s still a lot of people in the world who haven’t had exposure to this virus. Now, the virus is kind of interesting. It’s basically mutating around the spike protein, because we are seeing the mutations occur in the vaccinated community. There are mutations occurring in the unvaccinated, but those mutations are scattered amongst 29 proteins. The spike protein is just one of those 29 proteins. The way the body is targeting the neutralization is primarily through the receptor-binding domains on the spike protein, because that’s the way it’s being vaccinated against.
As you acquire those antibodies, that’s the first place you’re going to see mutations occur. In that population, you are seeing significant mutations occur in what we call, Wuhan, Alpha, Beta, Gamma, and Delta. Omicron is another animal. We kind of jokingly say, “Somehow the milk man came to visit,” because it’s not coming from Wuhan, Alpha, Beta, Gamma, or Delta. It’s a different virus.
I don’t want to go down that rabbit hole. It’s not actually my pure expertise, but that’s the thing we have to talk about as we go forward. Are there going to be other viruses that we will have to deal with? We definitely will. Respiratory viruses are normal. Will it be influenza? Will it be some other species? We’ll see. In general, there’s a lot of nuance in this. And in general, some viruses will compete with others.
That’s why you’ve seen low numbers of influenza right now, because the coronavirus family is out competing with that whole series of viruses, even paramyxoviruses. There’s a lot of different respiratory viruses, influenza, of course, being one everyone knows, and then also the coronavirus family. They compete with each other for us, the host.
Mr. Jekielek: The reason I’m asking about whether we might expect another wave is that during the pandemic we’ve had an approach that doesn’t work very well. The problem happens again, and you just do that same thing, but you do it harder. That’s been kind of a common theme. So there’s a lot of people that are concerned. For example, there were these lockdown policies that didn’t work, but you know what, if another wave comes, suddenly everyone has to wear masks and be locked down again.
Dr. Urso: You’re basically looking at the big picture. In a sense, we should step away for a second and talk about the big picture. What should we do? Should we lockdown healthy people? Absolutely not. It makes no sense. We don’t lockdown healthy people for respiratory viruses. Should we wash our hands and maybe do a little distancing? If we’re unhealthy, we should wash our hands. We should do some distancing. Those are all sensible things. If I am sick, I should distance myself from you. I shouldn’t bring my germs to you. It’s a respiratory virus. It’s going to go through the air. Are masks going to be effective? Not the types of masks that we are seeing here. There’s no evidence for that.
The whole approach has been corrupted, in a sense, by bad science. There’s no reason to wait for a vaccine when you have treatment that is basically for things that are on label, and then we go to locking down healthy people. No, we shouldn’t do that. It’s been proven that there’s 87 regions in the world where they did this and then looked at it, and they saw no benefit from lockdowns in terms of deaths. Should we mask people with masks that don’t work against respiratory viruses? Sometimes I say, “The data is there.” Sometimes I will say, “You can’t expect something to work that hasn’t worked for other viruses, when they are exactly the same size.”
In the beginning, I would have said, “It’s the same size virus and it likely won’t work.” They went and did the big Danish study, and guess what? It didn’t work. So there are cloth masks, N95 masks, and surgical masks. I was just wearing a surgical mask a few minutes ago, because I got out of surgery. They don’t work against viruses. We’ve always known that.
I have to do a viral lesion on someone next week, and I’m not going to wear that mask, because it doesn’t work against viruses, and I’ve known that forever. It’s called molluscum contagiosum. It’s going to aerosolize into the air, into the operating room. We have some strategies that we use to make sure that we don’t acquire that. And it’s not a surgical mask, it’s not an N95, and it’s not a cloth mask. None of those work for this problem.
The bottom line is we have lots of data, but have no good quality data saying that it works. Yet, we were forced to do it. The best data we have from the Danish study says that it doesn’t work. They came out with a really poorly designed trial from Bangladesh, I don’t know if they’re promoting this, but basically they said there was an 11 per cent difference in groups. But if you look at the study design, it’s an extremely poor quality study. It’s not a study that holds up to high scientific rigor. In all the scientific studies that have been done, randomized control trials have proven it to be not effective, except that one, which had very low scientific rigor.
So these things are easy to say. There was no reason to do those things. Should we have treated? Of course, why would we not treat inflammation? If I told you I had inflammation in my body and there’s no treatment for it—let’s forget about COVID—would you wonder about that? Would you say, “I wonder what’s wrong with that doctor? He’s not very smart, is he?” What if I said, “I have respiratory compromise,” and I said, “There’s no treatment for respiratory compromise.” Same thing, that doctor doesn’t know what he is talking about. “Is there treatment for blood clotting? No, there is no longer treatment for blood clotting.”
All of a sudden when the word COVID-19 came up, there was no treatment for inflammation, no treatment for respiratory compromise, and no treatment for blood clotting. How is that possible? It’s completely absurd. If you have things that you can attack a virus with that other people have done the work on over the last three or four decades, looking at these things, it is a strong biologic plausibility that mechanism can make an impact. Why would you not try them, when they’re safe and relatively low-risk?
The fact is we’ve used these drugs forever, they are old drugs that we’ve used forever. We know what they’re going to do, because we’ve already used them. Even if you tweak a drug one way or the other, you usually have a pretty good idea of what might happen. I think it was silly not to do it.
Mr. Jekielek: The bottom line is, if there is another wave of some sort of coronavirus, we have treatment.
Dr. Urso: No matter what shows up, there is treatment. If I say to you, “I cured diabetes.” You would say, “No, you haven’t done that.” But I treat diabetes, because the sugars go up, and things happen. It’s the same thing with hypertension. There is a way to mitigate damage in every disease, whether it’s COVID, whether it’s cancer, or whether it’s anything. There’s always something that’s potentially useful. That’s how we practice medicine. That’s the practice of medicine.
We look for the things that have the most evidence, the most biologic plausibility, and then we go from there. It’s a progression. That’s how you do drug design, which I have been doing for my whole career. For people who don’t know, my background is 11 years in a lab, two in a biochem, and nine in a tissue-culture lab. I’ve invented an FDA-approved drug. I’ve repurposed so many different things for so many different purposes. I look for the next pandemic to come, and I’m sure that people like me, and myself personally, will be able to come up with something that sounds reasonable.
Mr. Jekielek: You’re giving me a bit of your background. You just finished surgery before you came to this interview, hence your attire today. What do you do these days?
Dr. Urso: I’m a practicing physician, and have one of the biggest practices of its kind in the country. I’m an ophthalmologist. As I said, I was chief at one of the top cancer hospitals in the country at one time. I left to start a private practice in 2005. We built the practice into one of the biggest in the country. Private equity groups have come in and created some alliances that are bigger than ours. But we’ve got a big practice. I was actually just doing surgery on a patient right before I came for this interview, which is why I’m dressed like this. It was a reconstructive eyelid procedure.
Mr. Jekielek: Fascinating. These days you work a lot in treatment of COVID. For some people it might seem like a jump.
Dr. Urso: In Houston, Texas, some of the most prominent people in COVID are hospitalists. Robin Armstrong, Mary Talley Bowden, who is an ENT (Otolaryngologist,) and myself, have treated 1800 patients. Mary has treated about 2200 patients. We have a pediatrician/emergency room person, who’s treated about 10,000. And we have about 3000 doctors who didn’t treat any COVID patients, which is why I’m treating them. People are not going to do anything because they’re afraid, and because they don’t want to lose their paycheck. That’s the long story as to why this happened. It’s a bit of a shock.
I was reluctant, but I knew I had to do this, because if I didn’t, people were going to die unnecessarily. So reluctantly, I started treating. The first patient I treated was one of my best friends from medical school, he called me on March 10th.
He said, “I know you’ve been looking at this, and I trust you. I’m not going to the hospital, because I’ve already seen what’s happened overseas.” I treated him with steroids, Hydroxychloroquine, Erythromycin, vitamin-D, and aspirin. When I treated him with steroids, he said, “You’re going to treat me with steroids for this virus?” I said, “Absolutely.” And he said, “Are you sure?” I said, “You trust me, right?” And he said, “Yes.” I replied, “You’re day eight, and this virus is replication incompetent past day five or six.” He said, “How do you know that?”
I go, “I don’t. It’s a coronavirus, that’s what they all do. Every coronavirus in the whole world lasts for about five or six days. This one is no different. I know it’s a coronavirus and they’re calling it novel, but I don’t even know what that means. I don’t even know where that term even came from. They’re going to have another novel coronavirus a week from now, because it’s going to mutate a tiny bit. It’s going to be novel, also. They’re all novel. Every time you have a new pandemic or an epidemic, every single flu virus that we have every single year is novel or different from the one from the year before. So the word novel is nonsense. Novel is nonsense. They’re all novel. So first, get that out of your head. Second, know that respiratory disease in these viral illnesses is almost all inflammatory. It’s not pneumonia. It’s inflammatory. So there we go.” And he was like, “All right, fine. Just give me the medicine.” He took it and was better quickly.
At that point in time, I saw it work for myself. His family was sick too, and I knew I had to say something, because people were being told to go home. I was being told to go home. And I said, “I’m not going home.”
Mr. Jekielek: Fascinating. You’re basically being told, “Don’t work.”
Dr. Urso: No, they were telling me if I did work and used PPE, if I used a mask, that I might be criminally liable for wasting protective equipment in the middle of an emergency, when it’s hard to get a hold of. I got a little scared from that language. I hesitated a little bit. So I just decided not to wear the mask.
Mr. Jekielek: Let me get this straight. You were told you couldn’t do your eye work, or you were told you couldn’t do your COVID work, or any work?
Dr. Urso: This scared people so much at the beginning, because really my story is the same as everyone’s, and we all felt the same thing. We were told, “If you’re not emergency personnel, you need to go home.” Some of us here decided that we’re not going home, we’re going to see patients. We could only see emergency patients. So if a patient calls in with a floater or something like that, you could see them.
I decided that I was going to do more than that. I told my patients that had COVID, “If you have COVID, nobody is going to help you.” I said, “First, go through the chain. If no one’s going to help you, I’ll help you. Call your regular doctor. If no one’s going to see you and they don’t have a referral to someone else, and you’re going to not be seen by anybody, then call me and I’ll help you.”
So I ended up 1800 patients later. But all the doctors were afraid, because, first of all, they didn’t want to be in trouble and potentially lose their license. They stayed in business. Let’s say they were an ENT doctor and somebody had wax in their ear. That could wait, you can’t see that patient. So those kinds of patients were off limits. It could only be emergency personnel.
That was scary. Should I stay in business and keep my doors open, if I’m not doing an emergency? We decided to stay in business with our employees. We kept about 300. At the time we had 750 employees and we stayed in business with about half of them so we could keep the doors open. And of course, we were losing money because of that.
So our business went down to about 15 per cent of what we consider to be urgent. You have a bleed in the retina. You have floaters. Your eye hurts, it’s scratched. It might be infection, we don’t know. It just hurts real bad, it’s all red. We kept our doors open for these kinds of things. We also kept our doors open for people who had macular degeneration. If they don’t get their medicine, they’re going to go blind, so we get their medicine. So people were aware that we could do that.
But the scariest thing was the whole thing about the masks. Basically, if you weren’t wearing them, you could be criminally liable. In between all those mixed messages, a lot of people said, “I’m just going to take a week off, because it’s only going to be two weeks.” So everybody kind of went there and said, “Just let me take time off.”
I took zero days off, because I’ve never taken a day off. You can’t go to the bathroom, you don’t have to eat, and you don’t need to take a day off. You can ask all my employees about that, and what would they say? “There’s no days off, you can’t go to the bathroom, and you can’t eat.” Then, of course, I smile and say, “I’m just kidding.”
But seriously, that was scary. We didn’t know how aggressive they were going to be and how much was going to come down the pike at us. A lot of my docs that are partners of mine, quite a few of them, actually, decided to quit after this kept dragging out. We had the biggest practice in the country at the time, and over the course of the first year of COVID we lost 22 doctors. We were losing money every month, because there were not as many patients to see. They just decided, “I’m not comfortable.” And that’s what happened. It happened here, and happened everywhere.
Mr. Jekielek: I have heard, anecdotally, that a whole lot of doctors just stopped practicing over the course of the last two years. Do you have a sense of what that looks like right now?
Dr. Urso: Here in Texas, it’s been unbelievably busy, because people feel like COVID might be over. Once the news media flipped over to Russia, people are a lot less afraid. It’s like the constant messaging keeps people in fear. It really does work. Constant messaging works. So now that people are talking about Russia and Ukraine, they are not talking about COVID so much. There’s a lot of people that feel, “Oh, I think I’ll go back to the doctor.”
Mr. Jekielek: But are there actually less doctors now? Did the ones that quit come back?
Dr. Urso: No, they did not come back. In our practice, we’ve hired seven new doctors, all just out of residency. We’re seeing the young people are coming out and we have business for them, because people are coming back to the doctor for elective things now. So it’s changed a lot. Last year was actually reasonable, because people felt safe when they got the vaccine. I’m always happy to go down that rabbit hole too. But it made people feel safe that they had their vaccine, even though the triple-negative were dying at the highest rate.
Mr. Jekielek: Right. But didn’t that really only come out recently?
Dr. Urso: Most people have no idea about that. If you and I were in a room with 10 people from the general public, all of them would be shocked to hear that. Maybe one out of a 100 might know that.
Mr. Jekielek: Let’s take the opportunity to discuss this with the audience. Please tell me more about this.
Dr. Urso: As we looked at the data from the beginning of the pandemic, we had a hard time getting uncorrupted data. From the CDC, we still aren’t going to have data from Pfizer’s trials for who knows how long. They’re hiding a lot of the data. With the data they do have, as we got that data, we started finding interesting things, like, for instance, the bioavailability. What is the biodistribution of this product, this messenger-RNA lipid nanoparticle? Guess what? It distributes everywhere.
This is something that I would have known quite readily, because I work with lipid nanoparticles. I could have told you that lipid nanoparticles need a door crack, whereas a virus needs an open door, and a normal vaccine needs an open door.” A normal vaccine stays in the arm pretty much, 99 per cent or so. A lipid nanoparticle only needs a door crack to get out. A large majority of the lipid nanoparticles do not stay in the arm. In fact, we now know that a large portion goes into the lymph node right underneath here, and is still making spike protein 60 days later. That’s a wonderful study from [inaudible] called pharmacokinetics. That should have been looked at way before this product came out.
They never told people, “We’re going to stick it in your arm, but it’s going to show up in your lymph nodes. It’s going to show up in your brain. It’s going to show up in your ovaries, your bone marrow, your adrenal gland, your liver and your spleen. Then it’s going to track up through the vagus nerve and go to your basal ganglia.” All these things are happening. Why do I know? Because the studies have been done now. And if Pfizer did them, they didn’t tell anybody.
So I just told you it’s not staying in the arm. It produces spike protein for up to 60 days. The spike protein, as we know, is actually being found up to 15 months later in monocytes and other cells. It’s not being degraded. This is a big deal. People should know these things. It’s blocking p53, the guardian of the genome. It’s actually blocking MicroRNA-27a, which also causes upticks in colon cancer. It’s actually affecting many things that are going to increase cancerous, BRCA, the breast cancer gene. So these are things that should have been revealed ahead of time.
Mr. Jekielek: The studies to look at this, right?
Dr. Urso: These studies are done. These are not opinions. I’m not giving you any opinions. I’m just giving you data. So it goes everywhere. It’s blocking important tumor repair genes called p53. It’s blocking BRCA. It’s also messing with MicroRNA-27a, which causes uptick in colon cancer cells. It’s causing production for up to 60 days. It’s messing with Toll-like receptors 7 and 8, which both you and I have. They’re part of the overall genome of everybody in this room.
Those are important for immune surveillance of viruses. So we’re going to see this huge uptick in all the viruses that lay dormant in our body, like the herpes virus family. In my clinic, right now, I am seeing three to five people a week, because they know that I am taking a lot of time in my practice to do COVID. They’re coming to see me with long COVID, and they’re coming to see me with problems after the vaccine.
These people are coming in and they’re exhausted. They don’t feel good. What I’m finding is that a huge number of them have reactivated Epstein-Barr, herpes simplex, herpes zoster, and CMV. I have not had an interview with anyone where I’ve actually revealed that to any big audience. This is an incredibly important thing. A lot of people are looking at this long COVID, to see if it’s all viral-related problems specifically to the spike protein or to other issues. They don’t know that we’re seeing this huge reactivation in the herpes virus family. We have treatment for this, and it’s been working really, really well.
So these are things where we need to get the word out. We are also seeing a 40 per cent rise in deaths. As you know, these statistics are from the actuaries, in the 18 to 64 age range. Nobody filled them in to tell them to not let that news out. And in the 25 to 44 age range, for the last quarter of last year, we saw an 82 per cent rise in deaths. So there’s a lot of data out there that is very, very troubling, and most people are unaware.
It’s our job to let people know that this lipid nanoparticle messenger RNA platform—I don’t care what you attach to it—is always going to travel everywhere. It’s always going to be a problem. That’s why you see the distribution of disorders coming from this after the vaccine affects so many different organ systems, because it distributes everywhere.
I heard somebody say, “We don’t know why it does all these things.” Actually, we do know why, because it’s a lipid nanoparticle, and it goes everywhere. I tell people, “It’s like garlic.” So this is not something that’s controllable. It doesn’t matter if you’re doing it for RSV (Respiratory Syncytial Virus,) it doesn’t matter if you’re doing it for influenza—if you do a lipid nanoparticle platform—you’re asking for trouble. You’re asking to have an uncontrolled distribution pattern.
Mr. Jekielek: Yes. This is your drug designer hat now talking.
Dr. Urso: That’s my drug designer hat.
Mr. Jekielek: Yes, exactly. I want to go back to what you just said. There’s people coming to you every day with long COVID, and you’re saying that it’s common among these people to have these reactivated viruses.
Dr. Urso: Most of them are post-vaccine. Especially after the boosters, I started seeing a lot. I was seeing it early in the year, but not as much. After the third boosters, and some are now on the fourth boosters, we’re seeing a tremendous uptick in Epstein-Barr, cytomegalovirus, herpes zoster, herpes simplex viruses, and some mycoplasma.
Mr. Jekielek: And long COVID and these vaccine-effects are similar symptoms?
Dr. Urso: Absolutely. That’s what I was getting to, we are seeing that. There’s some unique differences in COVID and vaccine injury. The most unique one is myocarditis. In a lot of this long COVID, you’re going to see less neurologic issues than I’m seeing in the vaccine. Unless the patient was really sick, the blood-brain barrier is pretty protective against viruses. But it cannot keep out a lipid nanoparticle, which only needs a door crack. It fits through tight junctions. The reason a whole virus can’t get into the brain very easily is because the junctions are tight and it needs an opening. If there’s a lot of inflammation, it leaves openings.
The only place where you see a huge difference between the virus and the vaccine-effects is myocarditis. You see massive differences in the amount of damage. So overall we’re seeing a lot more severe injuries with the vaccine than we’re seeing with the long COVID. A lot of these long COVIDs and vaccine-effects are actually a constellation of symptoms that are best described as being viral disorders that are basically being reactivated.
Mr. Jekielek: Fascinating. There’s a massive area of research here that is being kickstarted on a broader scale. Are you seeing this through actually treating people?
Dr. Urso: We’ve decided that we need to let people know. We want other doctors to know, “Hey, look for the viral reactivation.” Bruce Patterson is also working on this, but he’s not talking about it at all. He’s not in the clinic seeing patients. In general, he’s getting sent patients and he’s getting a different type of patient than I’m getting. I’m getting the general public who are healthy enough to walk into my clinic. Some of them are pretty sick and staying at home, but people are saying, “Hey, go see him.”
But Bruce is probably getting people that are maybe even more sick, and so his work is going in a different direction, where his population is a little different. I’m seeing a lot of people that are going around with long COVID, half-functioning, but not completely dysfunctional. A lot of those are reactivated viral disorders from the Toll-like receptors 7 and 8 being disturbed.
Part two preview
Mr. Jekielek: Thank you all for joining me and Dr. Urso for this episode of American Thought Leaders. I’m your host, Jan Jekielek. Coming up in part two…
Dr. Urso: Basically, they took almost the exact same drug as Kaletra, dressed it up, put a box around it, and they’re selling it for what? Five billion.
Mr. Jekielek: Big pharmaceutical companies can make billions by essentially repackaging existing products, Dr. Urso says.
Dr. Urso: We have seen the ultimate demise of our healthcare system when it’s in the hands of bureaucrats.
Mr. Jekielek: Dr. Urso says, he’s now working with other prominent doctors to create both a national telehealth system, as well as an entirely new infrastructure of doctor-led medicine, where power is decentralized and less easily corrupted.
Dr. Urso: Once doctors became employees, during this pandemic, it made them very reluctant to speak out for various reasons.
Mr. Jekielek: Dr. Urso is a drug design and treatment specialist, an ophthalmologist, and former chief of orbital oncology at MD Anderson Cancer Center. This is American Thought Leaders, and I’m Jan Jekielek.
We live in an era of censorship and disinformation, and it can be really hard to know what’s true and what’s false in this information climate. To get honest information and insights you can trust, join us on Epoch TV. You can sign up for your 14 day free trial https://ept.ms/freetrialjan, that’s https://ept.ms/freetrialJAN.
Subscribe to the American Thought Leaders newsletter so you never miss an episode.
“Download EpochTV Ebook for free.
Follow EpochTV on social media: